PROMISE II Trial Met Primary Endpoint Therapy Demonstrates 76% Limb Salvage in Patients with Chronic Limb-Threatening Ischemia Who Otherwise Faced Amputation PARIS--(BUSINESS WIRE)--LimFlow SA, a ...

New data from the PROMISE III trial show the LimFlow transcatheter deep venous arterialization system achieved over 80% amputation-free survival at six months in 'no-option' chronic limb-threatening ...

Cynthia Elford loves to travel and hike, but a few years ago, her Type 1 diabetes made getting around nearly impossible. By 2018, the Pennsylvania grandmother faced the possibility of losing her right ...

ASHLAND — In 2024, UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for the treatment of chronic limb ...

CLEVELAND — According to the National Institutes of Health, nearly 400 people a day lose a leg or foot to diabetes, peripheral artery disease or neuropathy. But an experimental procedure, called ...

Transcatheter deep venous arterialization was tied to high rates of limb salvage and wound healing in patients with “no ...

DETROIT (March 21, 2024) – The first commercial procedure on a patient in Michigan using the LimFlow System was performed earlier this month by vascular and endovascular surgeon Tamer Boules, M.D., ...

CLEVELAND — Cindy Elford was the first patient at University Hospitals Cleveland Medical Center to have her leg saved by the LimFlow device. We met just after the procedure. Years later, she's still ...

LEBANON – November marks American Diabetes Month, a time to raise awareness and promote research related to diabetes. One of the more devastating impacts of the disease many diabetics face is chronic ...

COLLEGE STATION, Texas (KBTX)- This segment on The Three was paid for and sponsored by Davis Vein & Vascular. Davis Vein & Vascular is now offering a procedure aimed at saving the limbs of patients ...

For too long, there was nothing Dr. Miguel Montero-Baker could do to keep some of his patients from losing a foot or leg. Patients with health conditions such as diabetes and chronic kidney disease ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...